HUE062554T2 - Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárás - Google Patents

Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárás

Info

Publication number
HUE062554T2
HUE062554T2 HUE21190088A HUE21190088A HUE062554T2 HU E062554 T2 HUE062554 T2 HU E062554T2 HU E21190088 A HUE21190088 A HU E21190088A HU E21190088 A HUE21190088 A HU E21190088A HU E062554 T2 HUE062554 T2 HU E062554T2
Authority
HU
Hungary
Prior art keywords
pcta
gadolinium
complex
preparation
purification process
Prior art date
Application number
HUE21190088A
Other languages
English (en)
Hungarian (hu)
Inventor
Greneur Soizic Le
Alain Chenede
Martine Cerf
Myriam Petta
Emmanuelle Marais
Bruno François
Caroline Robic
Stephanie Louguet
Original Assignee
Guerbet Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet Sa filed Critical Guerbet Sa
Publication of HUE062554T2 publication Critical patent/HUE062554T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HUE21190088A 2019-01-17 2020-01-17 Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárás HUE062554T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1900432A FR3091873B1 (fr) 2019-01-17 2019-01-17 Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Publications (1)

Publication Number Publication Date
HUE062554T2 true HUE062554T2 (hu) 2023-11-28

Family

ID=67001953

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE21190088A HUE062554T2 (hu) 2019-01-17 2020-01-17 Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárás
HUE20701709A HUE060343T2 (hu) 2019-01-17 2020-01-17 Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárása

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE20701709A HUE060343T2 (hu) 2019-01-17 2020-01-17 Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárása

Country Status (28)

Country Link
US (3) US11590246B2 (enAn)
EP (2) EP3902800B1 (enAn)
JP (2) JP7071596B2 (enAn)
KR (2) KR102502862B1 (enAn)
CN (3) CN119552163A (enAn)
AR (1) AR117835A1 (enAn)
AU (1) AU2020208794B2 (enAn)
BR (1) BR112021014006B1 (enAn)
CA (1) CA3126268C (enAn)
CL (1) CL2021001868A1 (enAn)
CO (1) CO2021009261A2 (enAn)
DK (2) DK3943493T3 (enAn)
ES (2) ES2930136T3 (enAn)
FI (1) FI3943493T3 (enAn)
FR (1) FR3091873B1 (enAn)
HR (2) HRP20230678T1 (enAn)
HU (2) HUE062554T2 (enAn)
IL (1) IL284884B1 (enAn)
MA (2) MA55389A (enAn)
MX (1) MX2021008651A (enAn)
PH (1) PH12021551725A1 (enAn)
PL (2) PL3943493T3 (enAn)
PT (2) PT3902800T (enAn)
RS (1) RS64334B1 (enAn)
SG (1) SG11202107779SA (enAn)
TW (1) TWI811518B (enAn)
WO (1) WO2020148436A1 (enAn)
ZA (1) ZA202104994B (enAn)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3105610C (en) 2018-08-06 2024-05-28 Bracco Imaging Spa Gadolinium bearing pcta-based contrast agents
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
US20230339945A1 (en) * 2020-07-17 2023-10-26 Guerbet Method for preparing a chelating ligand derived from pcta
EP4222861A4 (en) * 2020-10-02 2024-10-02 Eagle Harbor Technologies, Inc. IONIC CURRENT DROP COMPENSATION
WO2024049087A1 (ko) * 2022-09-01 2024-03-07 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제
KR102845061B1 (ko) * 2022-09-01 2025-08-13 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4001655A1 (de) 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH04154729A (ja) 1990-10-16 1992-05-27 Nippon Mejifuijitsukusu Kk 磁気共鳴造影剤
IT1292128B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici
EP0992245A1 (en) 1998-09-16 2000-04-12 Goldham Bioglan Pharma GmbH Radio-contrast agents
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
FR2891830B1 (fr) 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US20090208421A1 (en) * 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
US8119817B2 (en) * 2009-09-29 2012-02-21 Degussa-Huels Ag Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline
EP2786768A1 (en) 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
WO2014174120A1 (fr) 2013-04-26 2014-10-30 Guerbet Formulation de produit de contraste et son procede de preparation associe
CN104188957B (zh) * 2014-05-28 2017-04-26 中国中医科学院西苑医院 一种防治再狭窄的药物及其制备和使用方法
US11155519B2 (en) * 2017-04-28 2021-10-26 Otsuka Pharmaceutical Factory, Inc. Method for manufacturing diastereomer of citric acid derivative
CA3105610C (en) 2018-08-06 2024-05-28 Bracco Imaging Spa Gadolinium bearing pcta-based contrast agents
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
FR3091873B1 (fr) 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Also Published As

Publication number Publication date
MA54626A (fr) 2022-04-20
CA3126268A1 (fr) 2020-07-23
CL2021001868A1 (es) 2022-01-21
US12064487B2 (en) 2024-08-20
IL284884A (en) 2021-08-31
JP2022508496A (ja) 2022-01-19
PL3943493T3 (pl) 2023-08-07
PT3943493T (pt) 2023-07-12
PT3902800T (pt) 2022-11-16
EP3902800B1 (fr) 2022-09-07
CN113735854A (zh) 2021-12-03
BR112021014006B1 (pt) 2023-05-02
CA3126268C (fr) 2024-01-09
EP3902800A1 (fr) 2021-11-03
RS64334B1 (sr) 2023-08-31
CN113735854B (zh) 2024-05-14
AU2020208794A1 (en) 2021-08-05
ES2930136T3 (es) 2022-12-07
ES2950118T3 (es) 2023-10-05
US20220062443A1 (en) 2022-03-03
HUE060343T2 (hu) 2023-02-28
FR3091873A1 (fr) 2020-07-24
KR102502862B1 (ko) 2023-02-23
JP2022009463A (ja) 2022-01-14
WO2020148436A1 (fr) 2020-07-23
CN119552163A (zh) 2025-03-04
AU2020208794B2 (en) 2023-01-12
CO2021009261A2 (es) 2021-12-10
KR20210109039A (ko) 2021-09-03
CN113646308B (zh) 2024-12-13
MA55389A (fr) 2022-01-26
EP3943493B1 (fr) 2023-04-19
CN113646308A (zh) 2021-11-12
AR117835A1 (es) 2021-08-25
DK3902800T3 (da) 2022-11-28
TW202043227A (zh) 2020-12-01
HRP20230678T1 (hr) 2023-09-29
EP3943493A1 (fr) 2022-01-26
DK3943493T3 (da) 2023-07-24
PL3902800T3 (pl) 2022-12-27
JP7321230B2 (ja) 2023-08-04
US20240358863A1 (en) 2024-10-31
TWI811518B (zh) 2023-08-11
US11590246B2 (en) 2023-02-28
FI3943493T3 (fi) 2023-07-19
KR102438394B1 (ko) 2022-09-01
ZA202104994B (en) 2023-04-26
US20230149568A1 (en) 2023-05-18
HRP20221402T1 (hr) 2023-01-06
IL284884B1 (en) 2025-05-01
BR112021014006A2 (pt) 2021-09-21
FR3091873B1 (fr) 2020-12-25
MX2021008651A (es) 2021-10-26
JP7071596B2 (ja) 2022-05-19
KR20210138134A (ko) 2021-11-18
PH12021551725A1 (en) 2022-04-11
SG11202107779SA (en) 2021-08-30

Similar Documents

Publication Publication Date Title
HUE062554T2 (hu) Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárás
HUE060073T2 (hu) Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási eljárása
SG11202109267UA (en) Blood flow rate measurement system
EP3362554A4 (en) MULTILAYER RESPIRATORY ORGANOIDS AND PROCESS FOR THE PREPARATION AND USE THEREOF
EP3337606A4 (en) PYROLYSATE ADSORBER FROM MICROCRYSTALLINE CELLULOSE AND PROCESS FOR THE PREPARATION AND USE THEREOF
PH12017550023A1 (en) A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
IL283453A (en) Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
SG11202113251QA (en) Process for the purification of lacto-n-neotetraose
EP4030970A4 (en) BREATHABLE CRADLE
ZA202005510B (en) A process for enterovirus purification and inactivation and vaccine compositions obtained thereof
IL282845A (en) A process for the preparation of optically enriched isoxazolines
DK3773511T3 (da) Oral tablet til induceret spytproduktion
ZA202000167B (en) Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
MX2017010625A (es) Alfa-1-microglobulina para usarse en la proteccion de los riñones en terapia con radionucleidos.
GB2582198B (en) Bassinet
HK40119100A (en) Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched pcta and preparation and purification process thereof
EP3741368A4 (en) CAPSULE FOR THE TREATMENT OF ULCERATIVE COLITIS
MA50962A (fr) Ensemble de prise d'empreinte dentaire
IL283633A (en) A process for preparing a cyclic dinucleotide
PT3514235T (pt) Composição para o tratamento de um doente que sofre de colite ulcerosa, assim como utilização da composição como medicamento
EP3492429A4 (en) METHOD FOR THE PRODUCTION OF A PLATE-MOLDED METAL-SILICA CONTAINER BULB AND A PLATFORMED METAL-SILICA CONTAINER BULB THEREWITH PRODUCED
EP4037707A4 (en) COMPOUNDS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS
EP4009975A4 (en) Compounds for hepatitis b treatment
GB201906778D0 (en) Purification process
CA191533S (en) Jewellery ring stretcher